ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
14 Sep 2023

Acarix changes Certified Adviser to Penser Bank AB

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser. Acarix AB has entered int...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Listing Regulation, News, Other, Regulatory
November 18, 2024
14 Sep 2023

Acarix changes Certified Adviser to Penser Bank AB

Acarix, a leader in acoustic and AI-based cardiac diagnostics, today announces a change of Certified Adviser.Acarix AB has entered into...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
11 Sep 2023

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be held on Th...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2023

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma torsdagen den 28 september 20...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2023

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the extra general meeting to be ...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish
November 18, 2024
11 Sep 2023

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org. nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma torsdagen den 28 septemb...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2023

Acarix beslutar om företrädesemission om cirka 54 MSEK fullt garanterad av bland annat en dansk life science fond

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HONGKONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Sep 2023

Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, MAR, News, Regulatory, Shares, Swedish
November 18, 2024
11 Sep 2023

Acarix beslutar om företrädesemission om cirka 54 MSEK fullt garanterad av bland annat en dansk life science fond

EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARE SIG DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AUSTRALIEN, HON...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, MAR, News, Regulatory, Shares
November 18, 2024
11 Sep 2023

Acarix resolves on a rights issue of approximately SEK 54 million fully guaranteed by, among others, a Danish life science fund

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, WHETHER DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, ...
Continue reading
author-avatar acarix
Press
August 6, 2024
04 Sep 2023

Acarix receives initial order from the emerging East African market

Acarix, a leader in acoustic and AI-based cardiac diagnostics, partners with Maeva Health, led by Dr. Peter Svalander, CEO, to launch t...
Continue reading
author-avatar acarix
Press
August 6, 2024
04 Sep 2023

Acarix erhåller första order från den växande östafrikanska marknaden

Acarix, ledande inom akustisk och AI-baserad hjärtdiagnostik, samarbetar med Maeva Health, under ledning av Dr. Peter Svalander, VD, fö...
Continue reading
  • «
  • ‹
  • 17
  • 18
  • 19
  • 20
  • 21
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.